Have you ever heard of “pharmacogenomics” or “pharmacogenomic testing”?
Researchers at the University of Alabama are exploring the knowledge and opinions held by the FX community about pharmacogenomic testing.
Pharmacogenomic testing helps doctors predict how a person will respond to medications based on their genetics. Recent research indicates that individuals living with FXS may benefit from personalized medical management, like pharmacogenomic testing, due to the wide spectrum of symptoms associated with FXS.
About the Study
Who can participate?
Anyone 18 years or older who identifies either as an individual living with FXS, a caregiver of someone living with FXS, or an individual living with the FXS premutation may participate in this study.
What will happen in the study?
If you agree to join this study, you will be asked to complete an online survey. This survey has about 20 questions and will take 15-20 minutes to complete. You do not need to complete the survey in one sitting. The survey will contain questions about you or your child’s experiences and knowledge of pharmacogenomic testing, thoughts about pharmacogenomics, and demographic information.
What are the good things that can happen from this research?
Researchers hope to learn more about the thoughts and feelings of the FX community so they can better understand and serve the community.
What are the bad things that can happen from this research?
Some of the survey questions may bring up uncomfortable topics related to decision-making or opinions. Additionally, questions may address past situations that are difficult to recall.
There may be other risks that we do not know about yet.
Will I or my child be paid to complete this study?
There is no compensation for completing this study.
Interested in Participating?
Our Most Recent Opportunities
Brain & Behavior Study
Researchers at Purdue University are conducting a natural history research study to learn about brain activity in females, ages18-60 years, living with the FMR1 premutation.
NFXF Gene Therapy Community Survey
Help the NFXF - share your thoughts on gene therapy.
Study: Mechanisms and biomarkers of disease progression in Fragile X-associated tremor/ataxia syndrome (FXTAS)
The University of Kansas BRAIN Lab is conducting a research study to learn about behavioral and brain differences associated with the Fragile X premutation. Males and females ages 50-80 living with the Fragile X premutation, with or without FXTAS, may be eligible to participate. The study includes remote & in-person visits at the University of Kansas.
Exploring Potential Barriers to the Fragile X Syndrome Cascade Screening Process
Researchers at the University of Memphis and Cincinnati Children's Hospital Medical Center are conducting a research study exploring the relationship between barriers and the FXS screening process among family members.
Grief and Bereavement Experiences of Children with Intellectual Disabilities
Researchers at the University of Maryland are looking to understand how children with Fragile X syndrome (FXS) and other intellectual disabilities grieve the loss of a loved one. If you are the parent or guardian of a child with FXS or another intellectual disability who has experienced the death of someone in their life when they were 5-17 years old, researchers want to talk to you.
Language Learning in Children: Vocabulary Acquisition in a Meaningful Context
The University of Washington's Neurodevelopmental Language and Learning (NeuDLL) Lab is conducting research addressing how children learn words in stories and the skills that support learning. Participation is remote and can be completed from home. Sessions are scheduled at your convenience.